Sale!

CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CAPN3 gene is associated with a condition known as Limb-girdle muscular dystrophy type 2A (LGMD2A), which is an autosomal recessive disorder. This condition primarily affects the muscles around the hips and shoulders (the limb-girdle area), leading to progressive weakness and wasting. The CAPN3 gene encodes for a protein called calpain 3, which plays a crucial role in muscle function and repair. Mutations in the CAPN3 gene disrupt the normal functioning of calpain 3, leading to the symptoms observed in LGMD2A.

To diagnose this condition, genetic testing of the CAPN3 gene can be performed. This test looks for mutations in the CAPN3 gene that are known to cause Limb-girdle muscular dystrophy type 2A. It is a vital tool for confirming the diagnosis, understanding the disease’s progression, and making informed decisions about management and treatment.

In the United Arab Emirates, DNA Labs UAE offers this genetic test for individuals suspected of having LGMD2A or for those who may be carriers of the condition. The test cost is 4400 AED. Conducting this test at DNA Labs UAE provides a reliable diagnosis, aiding in the proper management of the condition and potentially guiding family planning decisions for affected individuals or families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test

At DNA Labs UAE, we offer the CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test. This test is designed to analyze the CAPN3 gene for any mutations or variations that may be causing limb-girdle muscular dystrophy.

Test Components and Price

The price of the CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test is AED 4400.0. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA Card.

Report Delivery

After the sample is collected, the report will be delivered within 3 to 4 weeks.

Method

The CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type

This test is specifically designed for the diagnosis of neurological disorders, such as limb-girdle muscular dystrophy.

Doctor

The test is performed by a neurologist.

Test Department

The CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the condition.

Test Details

The CAPN3 gene is associated with a type of limb-girdle muscular dystrophy called autosomal recessive type 2A (LGMD2A). This genetic disorder is characterized by progressive muscle weakness and wasting, primarily affecting the muscles of the hips and shoulders.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of LGMD2A, NGS can be used to analyze the CAPN3 gene for any mutations or variations that may be causing the disease.

The NGS genetic test for CAPN3 gene mutations can help confirm a diagnosis of LGMD2A and provide valuable information for genetic counseling, disease management, and potential treatment options. It can also be used for carrier testing in individuals with a family history of the condition.

It’s important to note that a genetic test for LGMD2A should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name CAPN3 Gene Limb-girdle muscular dystrophy autosomal recessive type 2A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CAPN3 Gene Limb-girdle muscular dystrophy, autosomal recessive type 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CAPN3 Gene Limb-girdle muscular dystrophy, autosomal recessive type 2A
Test Details

The CAPN3 gene is associated with a type of limb-girdle muscular dystrophy called autosomal recessive type 2A (LGMD2A). This genetic disorder is characterized by progressive muscle weakness and wasting, primarily affecting the muscles of the hips and shoulders.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of LGMD2A, NGS can be used to analyze the CAPN3 gene for any mutations or variations that may be causing the disease.

The NGS genetic test for CAPN3 gene mutations can help confirm a diagnosis of LGMD2A and provide valuable information for genetic counseling, disease management, and potential treatment options. It can also be used for carrier testing in individuals with a family history of the condition.

It’s important to note that a genetic test for LGMD2A should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.